SEOUL, South Korea–(BUSINESS WIRE)– #AAPSPharmSci360–Dong-A ST, a Korean pharma company, presented preclinical data at AAPS PharmSci 360 2026 on developing Icotrokinra as a topical psoriasis treatment.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.